Material Type

• Blood (whole) (3)
• Dried whole blood (2)
• Isolated peripheral blood mononuclear cells (non viable) (1)
• Isolated peripheral blood mononuclear cells (viable) (1)
• Other (3)
• Plasma (double spun) (1)
• Plasma (single spun) (8)
• Saliva (2)
• Serum (4)
• Stool (1)
• Swab medium (2)
• Urine (random) (2)

Microscopic Assessment

• Affected (1)
• Not applicable (8)

Storage Temperature

• RT (2)
• -85°C to -60°C (8)
• Liquid nitrogen (1)

Preservation Type

• N/A (1)

Associated Data

• Biomarker datasets (1)
• Clinical records (6)
• Followup records (6)
• Freezer temperature logs (6)
• Microbiological results (4)
• Participant Ethnicity (3)
• Physiological/biochemical measurements (4)
• Pre-analytical data (3)
• Quality indicators (4)
• Survey data (3)
• Treatment records (4)

Timeframe

• Immediate (4)
• 0 - 3 months (7)
• 3 - 6 months (3)
• > 6 months (1)

Participant Count

• 1 - 10 (1)
• 11 - 100 (1)
• 101 - 500 (6)
• 10001 - 50000 (1)

Sex

• Both sexes (8)

Age Range

• Young child (2 - 6 years) (2)
• Child (6 - 12 years) (1)
• Adolescent (12 - 18 years) (1)
• Young adult (18 - 40 years) (6)
• Adult (> 40 years) (2)

Biobank Services

• Ability to recontact (3)
• Cell culture (2)
• Data analytics (4)
• Digital imaging (1)
• Infectious strain isolation (1)
• Molecular Extractions (2)
• Nucleic acid extraction (3)

Collection Type

• Clinical Trial (2)
• Cohort (2)
• Cross-sectional (1)
• Disease specific (2)
• Longitudinal (1)
• Population-based (1)

Consent Restriction

• No Commercial restriction (5)
• No Disease area restriction (6)
• No Genetic analysis restriction (8)
• No Human genetic analysis restriction (6)
• No restrictions (1)
• No Project specific restriction (7)
• No Scope of use restriction (3)

Collection Status

• Completed (2)
• In progress (6)
• Not-started (1)

Access Condition

• Open to applicants (3)
• Open only through collaboration (5)

Country

• Democratic Republic of the Congo (2)
• Peru (1)
• South Africa (1)
• Uganda (2)
• United States (2)

County